BBS Bioactive Valuation
| BONEH Stock | EUR 0.07 0 4.23% |
BBS Bioactive seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of BBS Bioactive Bone from examining the entity fundamentals such as Shares Owned By Insiders of 45.74 %, operating margin of (278.58) %, and Current Valuation of 14.53 M as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BBS Bioactive's price fluctuation is out of control at this time. Calculation of the real value of BBS Bioactive Bone is based on 3 months time horizon. Increasing BBS Bioactive's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BBS Bioactive is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BBS Stock. However, BBS Bioactive's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.068 | Real 0.0653 | Hype 0.07 | Naive 0.0551 |
The intrinsic value of BBS Bioactive's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence BBS Bioactive's stock price.
Estimating the potential upside or downside of BBS Bioactive Bone Substitutes helps investors to forecast how BBS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BBS Bioactive more accurately as focusing exclusively on BBS Bioactive's fundamentals will not take into account other important factors: BBS Bioactive Total Value Analysis
BBS Bioactive Bone Substitutes is currently forecasted to have takeover price of 14.53 M with market capitalization of 12.23 M, debt of 5.12 M, and cash on hands of 3.44 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BBS Bioactive fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.53 M | 12.23 M | 5.12 M | 3.44 M |
BBS Bioactive Asset Utilization
One of the ways to look at asset utilization of BBS is to check how much profit was generated for every dollar of assets it reports. BBS Bioactive Bone shows a negative utilization of assets of -0.15 percent, losing €0.001455 for each euro of assets held by the entity. Unproductive asset utilization signifies that the company is being less productive with each euro of assets it shows. Put another way, asset utilization of BBS Bioactive Bone Substitutes shows how inefficient it operates for each euro spent on its assets.BBS Bioactive Ownership Allocation
The market capitalization of BBS Bioactive Bone is €12.23 Million. BBS Bioactive Bone retains considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the entity is larger than the current market value, you may still be able to generate positive returns on investment in this company.BBS Bioactive Profitability Analysis
Net Loss for the year was (2.77 M) with loss before overhead, payroll, taxes, and interest of (56.95 K).About BBS Bioactive Valuation
An absolute valuation paradigm, as applied to BBS Stock, attempts to find the value of BBS Bioactive Bone based on its fundamental and basic technical indicators. By analyzing BBS Bioactive's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of BBS Bioactive's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of BBS Bioactive. We calculate exposure to BBS Bioactive's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BBS Bioactive's related companies.BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland. The company was founded in 2003 and is headquartered in Oulu, Finland. BBS Bioactive is traded on Helsinki Exchange in Finland.
8 Steps to conduct BBS Bioactive's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BBS Bioactive's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BBS Bioactive's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BBS Bioactive's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BBS Bioactive's revenue streams: Identify BBS Bioactive's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BBS Bioactive's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BBS Bioactive's growth potential: Evaluate BBS Bioactive's management, business model, and growth potential.
- Determine BBS Bioactive's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BBS Bioactive's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for BBS Stock analysis
When running BBS Bioactive's price analysis, check to measure BBS Bioactive's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BBS Bioactive is operating at the current time. Most of BBS Bioactive's value examination focuses on studying past and present price action to predict the probability of BBS Bioactive's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BBS Bioactive's price. Additionally, you may evaluate how the addition of BBS Bioactive to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets |